FDA Inspection 1342368 — Medion Grifols Diagnostics AG
The FDA completed an inspection of Medion Grifols Diagnostics AG on Aug 28, 2026 in Dudingen. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 28, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dudingen (Switzerland)